Literature DB >> 8224291

Chronic progressive conjunctival cicatrisation.

W Bernauer1, D C Broadway, P Wright.   

Abstract

The aim of this review is to demonstrate the spectrum of conditions encompassed by the term 'chronic progressive cicatrising conjunctivitis', to discuss mechanisms of conjunctival scar tissue formation and to describe the sequelae and therapeutic options in this potentially blinding condition. Chronic progressive cicatrising conjunctivitis is found in association with some mucocutaneous disorders (cicatricial pemphigoid, linear IgA disease), as part of paraneoplastic syndromes and after long-term treatment with certain systemic and topical medications (pseudo-pemphigoid). Recent studies on the conjunctiva of pemphigoid patients indicate that macrophages may play a pivotal role in chronic progressive conjunctival cicatrisation. They mediate the transition from inflammation to scar tissue by secretion of fibrogenic cytokines. There is evidence that similar mechanisms are involved in the other fibrosing conjunctival disorders. Sequelae of chronic conjunctival cicatrisation include the obstruction of lacrimal and meibomian glands, tear film alterations, trichiasis, keratopathy and blindness. Present possibilities and future options for the treatment of this condition are discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8224291     DOI: 10.1038/eye.1993.75

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  7 in total

Review 1.  Autoimmune bullous diseases: ocular manifestations and management.

Authors:  Caroline Laforest; Shyamala C Huilgol; Robert Casson; Dinesh Selva; Igal Leibovitch
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Drug-induced cicatrising granulomatous conjunctivitis.

Authors:  Alon Kahana; Marcus M Marcet; Daniel M Albert; Andrew T Thliveris
Journal:  Br J Ophthalmol       Date:  2007-05       Impact factor: 4.638

3.  Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.

Authors:  P J Pisella; P Pouliquen; C Baudouin
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

4.  The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation.

Authors:  W Bernauer; M J Elder; J N Leonard; P Wright; J K Dart
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-09       Impact factor: 3.117

5.  Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand.

Authors:  Samantha Bobba; Connor Devlin; Nick Di Girolamo; Denis Wakefield; Peter McCluskey; Elsie Chan; Mark Daniell; Stephanie Watson
Journal:  Eye (Lond)       Date:  2018-06-19       Impact factor: 3.775

6.  Cicatricial Conjunctivitis and Concurrent Clinical Features: A Case Study.

Authors:  Abdelsattar Farrag; Anita Chan; Louis Tong
Journal:  Clin Med Insights Case Rep       Date:  2022-05-18

7.  European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Authors:  H Rashid; A Lamberts; L Borradori; S Alberti-Violetti; R J Barry; M Caproni; B Carey; M Carrozzo; F Caux; G Cianchini; A Corrà; G F H Diercks; F G Dikkers; G Di Zenzo; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; A V Marzano; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; C Prost; S Rauz; B D van Rhijn; M Roth; E Schmidt; J Setterfield; G Zambruno; D Zillikens; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-10       Impact factor: 6.166

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.